-
NEWS
BD Reports Second Quarter Fiscal 2025 Financial ResultsLearn MoreRevenue of $5.3 billion increased 4.5% as reported, 6.0% currency-neutral and 0.9% organic GAAP and adjusted diluted EPS of $1.07 and $3.35, respectively Company updates full-year fiscal 2025...
-
NEWS
BD to Present at Bank of America Securities Health Care ConferenceLearn MoreBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference on...
-
BLOG
Together We AdvanceWe are proud to share a report of impact and progress made toward the goals and commitments we set for 2030+ to advance the health of our company, planet, communities and people.Learn More